Statistics about Health, Pharma & Medtech in United States
Statistics
- Injuries from crutches, canes and walkers in the U.S 2002-2010
- Injuries from crutches, canes and walkers in the U.S in 2010, by body part injured
- Annual change in U.S. hearing aid sales 2007-2022
- Doctors' trust in chatbots' abilities in the U.S. in 2023
- Yearly time savings using 3D-printed guides in surgery 2019, by specialty
- Possible cost savings using 3D-printed guides in surgery 2019
- Improved life quality due to hearing aids in select developed countries 2014-2015
- Elderly adults in the U.S. with a mobility aid who had fallen 2015, by age
- Safety and independence due to hearing aids in select developed countries 2014-2015
- Relationship improvement due to hearing aids in select developed countries 2014-2015
- Yearly cost savings using 3D-printed guides in surgery 2019, by specialty
- Possible time saved using 3D-printed guides in surgery 2019
- U.S. adults with hearing trouble who had used a hearing aid 2014, by age
- Reasons for nonuse among elderly adults in the U.S. with a mobility aid 2015
- Most prescribed hearing aid brands or manufacturers among U.S. audiologists 2018
- Preferred methods of choice for sharing wearable health data in the U.S. 2023
- Value of medical device imports from the U.S. to Taiwan 2014-2019
- Elderly adults in the U.S. with a mobility aid who had fallen 2015, by insurance
- Reasons for sharing data from personal devices with doctors in the U.S. 2023
- Injuries from crutches, canes and walkers in the U.S in 2010, by diagnosis
- Main medical chatbot applications for patients in the U.S. in 2023
- Types of chatbots used in medical practices in the U.S. in 2023
- Likelihood of choosing a doctor who uses wearable data in the U.S. 2023
- Biotech industry 2010: comparison of the US and Europe
- Alliances U.S. and Europe biotech companies by total potential value 2022
- Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
- U.S. bioscience employment by subsector 2021
- Cumulative number of drugs with biosimilars approved US and Europe 2006-2018
- U.S. bioscience establishments totals 2018-2021
- Number of U.S. bioscience establishments by subsectors 2021
- U.S. bioscience employment totals 2018-2021
- Disparities median price Lantus by select countries 2019
- U.S. top prescribed drugs based on sales 2022
- Number of biotech companies in the U.S. 2012-2016
- Price increase of select biotech drugs in the U.S. during January 2021
- U.S. bioscience employment distribution 2021 by subsector
- U.S. states with large employment in drugs and pharmaceuticals 2021
- Number of trials investigating Perjeta by country 2024
- Comparison WAC of Herceptin vs biosimilars in the U.S. Q2 2020
- U.S. biotech industry R&D expense
- CBD market size distributed by pharmacies and practitioners in the U.S. 2019-2026
- Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
- Medical cannabis market size in the United States by type 2019 and 2025
- U.S. specialists and familiarity with biosimilars 2021
- Cell-free DNA based cancer diagnostic and screening market US vs. world 2020
- COVID-19 vaccine and willingness among U.S. adults Dec 2020 - Apr 2022
- Number of biosimilar drugs becoming available United States 2015-2022
- Annual salaries of U.S. biotech sales representatives in the U.S. 2016-2019
- Sales per employee of select U.S. biotech and drugs companies Q3 2023
- Gross profit margin of select U.S. biotech and drugs companies Q3 2023
- Comparison ASP Herceptin vs biosimilars in the U.S. Q2 2020
- U.S. average annual wages per employee by industry 2021
- Comparison WAC of Remicade vs biosimilars in the U.S. as of Q3 2020
- Comparison ASP of Remicade vs biosimilars in the U.S. Q3 2020
- COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
- CBD pharmaceuticals market size in the United States 2019-2026
- U.S. bioscience industry revenue by subsector
- U.S. and Europe's selected anti-CD19 Car-T therapy sales forecast 2024
- Share of capital allocation among big biotechs in U.S. and Europe by type 2014-2019
- U.S. bioscience-related patents by segment 2018-2021
- Top U.S. states based on academic bioscience R&D expenditure 2020
- U.S. metropolitan areas by employment in research and medical laboratories 2021
- U.S. bioscience venture capital investments 2009-2021
- Major biologics to lose patent protection 2015-2020 by EU5 and U.S. revenue
- U.S. adults that used commercial genetic testing for select reasons 2018
- Total raised capital in U.S. and Europe biotechnology industry 2015-2022
- Total stem cell research funding by the National Institutes for Health 2013-2025
- Public U.S. biotech companies R&D spending by region 2021
- Total genetics funding by National Institutes for Health 2013-2025
- IPOs in U.S. and Europe biotechnology industry 2000-2022
- Venture capital in U.S. and Europe biotechnology industry 2015-2022
- Select M&As involving U.S. and European biotech companies 2022
- biotechnology funding by National Institutes for Health 2013-2025
- U.S. veterinary medicine and vaccines import and export value in 2016
- Value of top U.S. biotech IPOs 2022
- Amount of top U.S. biotech venture financings 2022
- Select COVID-19 vaccine pricing and funding as of August 2020
- Market capitalization of U.S. biotech companies by region 2021
- Humira U.S. price change 2021-2022
- mRNA vaccine and therapy market value U.S. 2020-2030
- CAGR of the biosimilars market in Europe and the United States 2018-2025
- Size of the total U.S. vaccine market 2014-2024
- Size of the U.S. vaccine market by age 2014-2024
- Biotech vs. Web 2.0 share of total U.S. venture investment 2005-2010
- Net loss Intellia Therapeutics 2014-2023
- Revenue of Intellia Therapeutics 2015-2023
- R&D expenses of Intellia Therapeutics 2014-2023
- Total assets of Intellia Therapeutics 2014-2023
- U.S. public biotech companies revenue by region 2021
- Number of public biotech companies in the U.S. 2021 by region
- BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- U.S. biotech companies market capitalization 1994-2016
- U.S. adults that had genetic testing for cancer risk as of 2018
- Likelihood for future genetic testing use in U.S. adults in 2018, by type
- Influences for seeking genetic testing among U.S. adults in 2018, by test type
- Influences for likely seeking future genetic testing in the U.S. 2018, by test type
- Legal cannabis industry investments on biotech in the U.S. 2015-2017
- U.S. biological product manufacturing gross output 1998-2016
- First biosimilar marketing initiatives by MCOs in U.S. 2015
- Value of biological product manufacturing shipments 1998-2011